SCHEMBL7487692

SCHEMBL7487692

CNN1CCCC[C@H](c2ccc(Br)nc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PROKR1 Q8TCW9 5/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ CHRNB2 P17787 2/20 0.35
▸ CHRNA4 P43681 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ DRD2 P14416 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ DRD5 P21918 1/20 0.33
▸ DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7485261 1.00 PROKR1 (0.35) PROKR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7105311 0.96 CHRNB2 (0.39) PROKR1CHRNB2CHRNA4DRD2DRD1
SCHEMBL7103400 0.90 CHRNB2 (0.35) SLC6A2SLC6A4SLC6A3CHRNB2CHRNA4
SCHEMBL7488149 0.85 CHRNB2 (0.39) CHRNB2CHRNA4KDM4EGLAHTT
SCHEMBL7098400 0.84 ALDH1A1 (0.41) PROKR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7103962 0.84 ALDH1A1 (0.41) PROKR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7098495 0.80 CHRNB2 (0.42) PROKR1CHRNB2CHRNA4
SCHEMBL7098837 0.79 ALDH1A1 (0.44) PROKR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7098418 0.79 ALDH1A1 (0.44) PROKR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7102607 0.78 SLC6A2 (0.41) PROKR1SLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 — — EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 — — WO disclosed
Send feedback